17-4933086-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BA1
This summary comes from the ClinGen Evidence Repository: The missense variant NM_000173.7(GP1BA):c.482C>T (p.Thr161Met) is associated with the polymorphism HPA-2. Moreover, the Grpmax filtering allele frequency in gnomAD v4.1 is 0.2237 (based on 16982/74950 alleles) in African/African American population, which is significantly higher than the ClinGen PD VCEP threshold (>0.001) for BA1. Additionally, the computational predictor REVEL gives a score of 0.041, which is below the ClinGen PD VCEP threshold of <0.25 predicting no damaging effect on GP1BA function and the SpliceAI score is zero (BP4). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive Bernard-Soulier syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BA1 and BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA8314782/MONDO:0009276/079
Frequency
Consequence
NM_000173.7 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndromeInheritance: AR Classification: DEFINITIVE Submitted by: Illumina
- congenital myasthenic syndrome 4AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- congenital myasthenic syndrome 4BInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- congenital myasthenic syndrome 4CInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GP1BA | NM_000173.7 | c.482C>T | p.Thr161Met | missense_variant | Exon 2 of 2 | ENST00000329125.6 | NP_000164.5 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.125 AC: 19005AN: 152046Hom.: 1563 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0977 AC: 24317AN: 249022 AF XY: 0.0938 show subpopulations
GnomAD4 exome AF: 0.0840 AC: 122738AN: 1461638Hom.: 5913 Cov.: 39 AF XY: 0.0832 AC XY: 60522AN XY: 727094 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.125 AC: 19039AN: 152164Hom.: 1564 Cov.: 32 AF XY: 0.125 AC XY: 9332AN XY: 74386 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
This variant is associated with the following publications: (PMID: 12775575, 18417193, 23413192, 15686464) -
not specified Benign:1
- -
Bernard Soulier syndrome Benign:1
The missense variant NM_000173.7(GP1BA):c.482C>T (p.Thr161Met) is associated with the polymorphism HPA-2. Moreover, the Grpmax filtering allele frequency in gnomAD v4.1 is 0.2237 (based on 16982/74950 alleles) in African/African American population, which is significantly higher than the ClinGen PD VCEP threshold (>0.001) for BA1. Additionally, the computational predictor REVEL gives a score of 0.041, which is below the ClinGen PD VCEP threshold of <0.25 predicting no damaging effect on GP1BA function and the SpliceAI score is zero (BP4). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive Bernard-Soulier syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BA1 and BP4. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at